Prognostic and Clinicopathological Significance of E-Cadherin in Pancreatic Cancer Patients: A Meta-Analysis

Pengbo Wang, Zengkuan Zhu

Open source

DOI
10.3389/fonc.2021.627116
Published
2021-04-12
Container
Frontiers in Oncology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2021.627116,
  title = {Prognostic and Clinicopathological Significance of E-Cadherin in Pancreatic Cancer Patients: A Meta-Analysis},
  author = {Pengbo Wang and Zengkuan Zhu},
  year = {2021},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2021.627116},
  url = {https://doi.org/10.3389/fonc.2021.627116}
}

RIS

TY  - JOUR
TI  - Prognostic and Clinicopathological Significance of E-Cadherin in Pancreatic Cancer Patients: A Meta-Analysis
AU  - Pengbo Wang
AU  - Zengkuan Zhu
PY  - 2021
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2021.627116
UR  - https://doi.org/10.3389/fonc.2021.627116
ER  - 

APA

Wang, P., & Zhu, Z. (2021). Prognostic and Clinicopathological Significance of E-Cadherin in Pancreatic Cancer Patients: A Meta-Analysis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2021.627116

Source records